Cartesian Therapeutics, Inc. Quarterly Goodwill in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Cartesian Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2022 to Q3 2024.
  • Cartesian Therapeutics, Inc. Goodwill for the quarter ending September 30, 2024 was $48.2M.
Goodwill, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $48.2M Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $48.2M Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $48.2M Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $48.2M +$48.2M Dec 31, 2023 10-Q 2024-11-07
Q4 2022 $0 Dec 31, 2022 10-K 2024-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.